Item
MAXI-GEL®542 (11300115)
This product is labeled as 100% Food Starch Modified.
Starch
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
Locations
Location name | Address |
---|---|
Tate & Lyle Solutions USA LLC | 5450 Prairie Stone Parkway Hoffman Estates, IL 60192 |
Tate & Lyle Solutions USA LLC - Sagamore | 2245 Sagamore Pkwy Lafayette, IN 47904 |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergens | Tate & Lyle Solutions USA LLC - Sagamore | Allergens.pdf | 7/21/2023 | 7/20/2025 |
Country of Origin | Tate & Lyle Solutions USA LLC - Sagamore | Country of Origin.pdf | 3/14/2024 | 3/14/2027 |
Heavy Metal | Tate & Lyle Solutions USA LLC - Sagamore | CUL_20230201_CODEX.pdf | 2/1/2023 | 1/31/2025 |
HARPC Food Safety Plan (Item) | Tate & Lyle Solutions USA LLC - Sagamore | CUL_20240102_PREVENTATIVE CONTROLS COMPLIANCE.pdf | 1/2/2024 | 1/1/2027 |
HACCP | Tate & Lyle Solutions USA LLC - Sagamore | CUL_20250102_GMP HACCP.pdf | 1/2/2025 | 1/2/2028 |
Lot Code | Tate & Lyle Solutions USA LLC - Sagamore | CUL_20250102_LOT CODE.pdf | 1/2/2025 | 1/2/2028 |
Dietary Supplement Questionnaire | Tate & Lyle Solutions USA LLC - Sagamore | Dietary Supplement Questionnaire.pdf | 1/31/2022 | 1/31/2023 |
FSVP Assessment Form | Tate & Lyle Solutions USA LLC - Sagamore | FSVP Assessment Form.pdf | 10/31/2024 | 10/31/2025 |
Halal | Tate & Lyle Solutions USA LLC - Sagamore | HAL_SAG_20231113_EXP20250131_SAGAMORE.pdf | 11/13/2023 | 1/31/2025 |
Item Questionnaire | Tate & Lyle Solutions USA LLC - Sagamore | Item Questionnaire.pdf | 1/31/2025 | 1/31/2028 |
Kosher | Tate & Lyle Solutions USA LLC - Sagamore | KOS_SAG_20241202_EXP20251231_SAGAMORE.pdf | 12/2/2024 | 12/31/2025 |
CoA Sample | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_CUC_SAG_20231228_Exampel COA SA23L02194 50lb.pdf | 12/28/2023 | 12/27/2025 |
Label Sample | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PAC_SAG_20241009_packaging.pdf | 10/9/2024 | 10/9/2025 |
BSE - TSE | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PIS_SAG_20220112.pdf | 1/12/2022 | 1/11/2025 |
EtO Statement | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PIS_SAG_20220112.pdf | 1/12/2022 | 1/12/2024 |
California Prop. 65 | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Irradiation Status Statement | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Lot Code | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2025 |
Gluten | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/31/2023 |
BSE - TSE | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2025 |
GMO | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Sewage Statement | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
EtO Statement | Tate & Lyle Solutions USA LLC | MAXIGEL 542_PIS_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Sewage Statement | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PIS_SAG_20230610.pdf | 6/10/2023 | 6/9/2025 |
California Prop. 65 | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PIS_SAG_20230610.pdf | 6/10/2023 | 6/9/2025 |
Irradiation Status Statement | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PIS_SAG_20240113.pdf | 1/13/2024 | 1/12/2026 |
GMO | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_PIS_SAG_20240113.pdf | 1/13/2024 | 1/12/2026 |
Label Sample | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SAG_LAB_2021.jpg | 6/23/2022 | 6/23/2023 |
Safety Data Sheet (SDS) | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SDS_SAG_20220301.PDF | 3/1/2022 | 2/28/2025 |
Safety Data Sheet (SDS) | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SDS_SAG_20250103.PDF | 1/3/2025 | 1/3/2028 |
Organic | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20220112.pdf | 1/12/2022 | 1/12/2024 |
GRAS/NDI/ODI Statement | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20220112.pdf | 1/12/2022 | 1/11/2025 |
Label Guidance | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20220112.pdf | 1/12/2022 | 1/12/2024 |
Label Claims | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20220112.pdf | 1/12/2022 | 1/12/2024 |
Ingredient Statement | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/31/2023 |
Product Specification Sheet | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/30/2025 |
Organic | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/31/2024 |
Shelf Life | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/30/2025 |
GRAS/NDI/ODI Statement | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/30/2025 |
Label Guidance | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Label Claims | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Vegan/Vegetarian Statement | Tate & Lyle Solutions USA LLC | MAXIGEL 542_SPE_SAG_20220331.pdf | 3/31/2022 | 3/30/2024 |
Vegan/Vegetarian Statement | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20230610.pdf | 6/10/2023 | 6/9/2025 |
Gluten | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20240113.pdf | 1/13/2024 | 1/12/2025 |
Shelf Life | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 542_SPE_SAG_20250111.pdf | 1/11/2025 | 1/11/2028 |
Product Specification Sheet | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL 617_SPE_SAG_20250111.pdf | 1/11/2025 | 1/11/2028 |
Ingredient Statement | Tate & Lyle Solutions USA LLC - Sagamore | MAXIGEL SERIES_COO_ING_SAG_20250102.pdf | 1/2/2025 | 1/2/2028 |
Natural | Tate & Lyle Solutions USA LLC - Sagamore | NAT_TLS_E_INS 1442_GMO_20220225.pdf | 2/25/2022 | 2/25/2023 |
National Bioengineered Food Disclosure Standard (Simplified) | Tate & Lyle Solutions USA LLC - Sagamore | National Bioengineered Food Disclosure Standard (Simplified).pdf | 1/31/2025 | 1/31/2028 |
WADA/NSF/NFL Statement | Tate & Lyle Solutions USA LLC - Sagamore | NOL_20230201_MELAMINE_PHTHALATES_BPA_RES SOL_WADA_STEVIA_TAPIOCA_MONK FRUIT_ERYTHRITOL_CORN_POTATO PRODUCTS.pdf | 2/1/2023 | 1/31/2025 |
Phthalate Esters Letter | Tate & Lyle Solutions USA LLC - Sagamore | NOL_20230201_MELAMINE_PHTHALATES_BPA_RES SOL_WADA_STEVIA_TAPIOCA_MONK FRUIT_ERYTHRITOL_CORN_POTATO PRODUCTS.pdf | 2/1/2023 | 2/1/2024 |
Melamine | Tate & Lyle Solutions USA LLC - Sagamore | NOL_20230201_MELAMINE_PHTHALATES_BPA_RES SOL_WADA_STEVIA_TAPIOCA_MONK FRUIT_ERYTHRITOL_CORN_POTATO PRODUCTS.pdf | 2/1/2023 | 2/1/2024 |
Residual Statement | Tate & Lyle Solutions USA LLC - Sagamore | NOL_20230201_MELAMINE_PHTHALATES_BPA_RES SOL_WADA_STEVIA_TAPIOCA_MONK FRUIT_ERYTHRITOL_CORN_POTATO PRODUCTS.pdf | 2/1/2023 | 2/1/2024 |
No Animal Ingredient Statement | Tate & Lyle Solutions USA LLC - Sagamore | NOL_20240102_NO ANIMAL_STEVIA_SUCRALOSE_TAPIOCA_MONK FRUIT_ERYTHRITOL_CORN_CHICKPEA_POTATO PRODUCTS.pdf | 1/2/2024 | 1/1/2025 |
Animal Testing Statement | Tate & Lyle Solutions USA LLC - Sagamore | NOL_20250102_NO ANIMAL_STEVIA_SUCRALOSE_TAPIOCA_MONK FRUIT_ERYTHRITOL_CORN_CHICKPEA_POTATO PRODUCTS.pdf | 1/2/2025 | 1/2/2027 |
Nutrition | Tate & Lyle Solutions USA LLC - Sagamore | Nutrition.pdf | 12/15/2023 | 12/14/2026 |
Food Contact Packaging Certificate of Compliance | Tate & Lyle Solutions USA LLC - Sagamore | PAC_20230201_PACKAGING MATERIAL DIRECT CONTACT WITH FOOD_NO PFA'S.pdf | 2/1/2023 | 1/31/2025 |
HACCP Process Flow Diagram | Tate & Lyle Solutions USA LLC - Sagamore | PCF_TLS_SAG_STARCH HACCP_20250102.pdf | 1/2/2025 | 1/2/2027 |
Pesticide | Tate & Lyle Solutions USA LLC - Sagamore | PES_GLYPHOSATE_SAG_DENT_WAXY_20240318_REPORTS.pdf | 3/18/2024 | 3/18/2026 |
Suitability Requirements | Tate & Lyle Solutions USA LLC - Sagamore | Suitability Requirements.pdf | 7/11/2022 | 7/10/2025 |
-
Responds quickly
-
Documents Up to Date
- 21 locations
- 291 items
- 336 documents